Company Filing History:
Years Active: 2022
Title: **Innovative Contributions of Anja Katzschmann in Fusion Protein Technology**
Introduction
Anja Katzschmann, a distinguished inventor based in Halle/Saale, Germany, has made significant strides in the field of biomedical research. Her innovative work is encapsulated in a patent that showcases her expertise in fusion protein technology, particularly in applications related to cancer diagnosis and treatment.
Latest Patents
Anja Katzschmann holds a notable patent titled "Fusion proteins with specificity for ED-B and long serum half-life for diagnosis or treatment of cancer." This invention focuses on fusion proteins that include at least one extradomain B of fibronectin (ED-B), a binding domain exhibiting high stability in serum. The fusion protein is designed to comprise at least one APS domain consisting of up to approximately 80 amino acids, primarily composed of alanine, proline, and serine, with the option to include aspartic acid. Additionally, it contains at least one coupling site featuring a cysteine, which enhances the protein's utility for various medical applications, particularly in diagnosing and treating cancer or cardiovascular diseases.
Career Highlights
Katzschmann is affiliated with Navigo Proteins GmbH, a company that is dedicated to developing innovative protein technologies. Her role in the organization has been pivotal in advancing research in fusion proteins, enabling significant contributions to healthcare and medicine.
Collaborations
Throughout her career, Anja Katzschmann has collaborated with several esteemed colleagues, including Erik Fiedler and Ulrich Haupts. These collaborations have contributed to a robust research environment and have fostered advancements in protein engineering and medical applications.
Conclusion
Anja Katzschmann’s contributions to the field of biomedical research, particularly through her innovative patent on fusion proteins, illustrate her commitment to enhancing healthcare solutions. Her collaborations and work at Navigo Proteins GmbH position her as a notable inventor who is advancing the frontier of medical treatments for serious health conditions like cancer.